The British In Vitro Diagnostics Association (BIVDA) welcomes the measures in today’s Budget that provide additional investment in health technologies for the NHS and support the Government’s ambition to deliver care closer to patients’ homes. The Chancellor has committed £300m in further capital funding to deploy technology that enhances patient outcomes and NHS service productivity, while 250 Neighbourhood Health…
Ben KempNovember 26, 2025
Date and Time: Thursday 4th December, 11am to 3:30pm Make sure to register for BIVDA's workshop with the MHRA on the proposed classification rules, intended to be introduced under the Pre-Market SI. This is a crucial opportunity to work through the proposed IVD classification changes to the UK MDR with the MHRA and fellow BIVDA members. Members can register here.
Ben KempNovember 26, 2025
Date & Time: 16th December, 1pm to 2pm Nataliya Nedkova, Founder of NN Translations, will share how to navigate translation challenges & work best with LSPs & translators. Translation in the IVD and medical device sector goes far beyond converting words from one language to another. It requires regulatory awareness, linguistic precision, and seamless collaboration between manufacturers, LSPs, and translators.…
Ben KempNovember 26, 2025
MHRA-led study reveals major inconsistencies in global microbiome research A landmark international study led by the UK’s Medicines and Healthcare products Regulatory Authority (MHRA) has exposed significant variability in microbiome research methods across the world, highlighting an urgent need to adopt unified standards for the global harmonisation of gut microbiome research. The study involved leading laboratories across multiple countries testing identical samples…
Ben KempNovember 26, 2025
On the eve of World AMR Awareness Week, UKHSA released their latest ESPAUR report. The report, which monitors antimicrobial utilisation and resistance in England annually, revealed the following alarming statistics: Deaths in people with an antibiotic-resistant infection increased by 16.6% between 2023 and 2024 An average of 400 new cases of antibiotic-resistant infections each week in 2024 A 9.3% rise…
Ben KempNovember 25, 2025
Last week, Helen attended a Fleming Initiative event titled 'Nobel Prize to Now' during World AMR Awareness Week, which commemorated Sir Alexander Fleming’s discovery of Penicillin and subsequent Nobel Prize ahead of the 80th anniversary next month. The event, which opened with an address from the Prince of Wales, consisted of a series of panels and talks led by leading…
Ben KempNovember 25, 2025
BIVDA member CPI has published five reports offering deep insights into the challenges facing MedTech companies and the opportunities to overcome them. CPI are inviting MedTech companies, industry partners, and investors to work with them to amplify these findings and collaborate on solutions that will strengthen the UK’s innovation ecosystem. 1. Pre-competitive gaps in UK MedTech This report identifies major opportunities…
Ben KempNovember 25, 2025
BIVDA was pleased to participate in the UK–India Medical Devices and MedTech Roundtable held at the House of Lords. The event was organised by the Indo-British Business Forum and hosted by Baroness Sandy Verma, bringing together industry leaders to discuss the future of medtech collaboration between the two nations. BIVDA Treasurer Jag Grewal (pictured) attended on behalf of the organisation.…
Ben KempNovember 25, 2025